- Review
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and glucose-dependent insulinotropic polypeptide receptor agonists (GIP RAs) are incretin mimetics that have increased in use in the management of type 2 diabetes and obesity. Understanding the po...

